Dicker, A P <br/><br/>
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.  [electronic resource] 

 -  Seminars in urologic oncology  May 2000 
 - 152-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1081-0943 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Algorithms<br/>Brachytherapy--methods<br/>Cell Division--radiation effects<br/>Cell Survival--radiation effects<br/>Dose-Response Relationship, Radiation<br/>Half-Life<br/>Humans<br/>Iodine Radioisotopes--administration & dosage<br/>Male<br/>Palladium--administration & dosage<br/>Prostatic Neoplasms--pathology<br/>Radioisotopes--administration & dosage<br/>Radiotherapy Dosage<br/>Radiotherapy Planning, Computer-Assisted<br/>Therapeutic Equivalency<br/>Time Factors